Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement Diana A. GorogRichard C. Becker ReviewPaper Open access 11 June 2020 Pages: 1 - 11
Using big data to retrospectively validate the COMPASS-CAT risk assessment model: considerations on methodology Ilias NikolakopoulosSoheila NourabadiAlex C. Spyropoulos BriefCommunication 20 June 2020 Pages: 12 - 16
An international survey of clinicians regarding their management of venous thromboembolism following the initial 3–6 months of anticoagulation E. Banham-HallA. AllisonW. Thomas OriginalPaper 26 June 2020 Pages: 17 - 24
Hyperacute multi-organ thromboembolic storm in COVID-19: a case report Sarah ChibaneGuillaume GibeauSylvain Lanthier BriefCommunication 06 June 2020 Pages: 25 - 28
Pharmacologic therapeutic options for thromboprophylaxis in COVID-19 Chia Siang KowSyed Shahzad Hasan Letter to the Editor 28 June 2020 Pages: 29 - 30
Impact of Coronavirus Disease 2019 outbreak on acute coronary syndrome admissions: four weeks to reverse the trend Marie Hauguel-MoreauRémy PillièreNicolas Mansencal Report 29 June 2020 Pages: 31 - 32
DVT incidence and risk factors in critically ill patients with COVID-19 Shujing ChenDingyu ZhangJinjun Jiang OriginalPaper Open access 30 June 2020 Pages: 33 - 39
Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis B. Mestre-GómezR. M. Lorente-RamosInfanta Leonor Thrombosis Research Group OriginalPaper 29 June 2020 Pages: 40 - 46
Thrombin Generation and other hemostatic parameters in patients with atrial fibrillation in use of warfarin or rivaroxaban Rita Carolina Figueiredo DuarteDanyelle Romana Alves RiosMaria das Graças Carvalho OriginalPaper 06 May 2020 Pages: 47 - 57
Incidence and consequences of resuming oral anticoagulant therapy following hematuria and risks of ischemic stroke and major bleeding in patients with atrial fibrillation Chun-Li WangVictor Chien-Chia WuShang-Hung Chang OriginalPaper 14 May 2020 Pages: 58 - 66
Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center Megan Kunka FritzScott E. KincaidGeorge A. Davis OriginalPaper 23 May 2020 Pages: 67 - 73
Stroke and left atrial thrombi after cryoballoon ablation of atrial fibrillation: incidence and predictors. Results from a long-term follow-up Francesco SantoroNatale Daniele BrunettiChristian H. Heeger OriginalPaper 23 May 2020 Pages: 74 - 80
Right drug, wrong dosage: insights from the PAVE-AF antithrombotic study in older patients with atrial fibrillation Stylianos TzeisParaskevi Savvarithe PAVE-AF study group OriginalPaper Open access 09 June 2020 Pages: 81 - 88
PEAR1 polymorphisms as a prognostic factor in hemostasis and cardiovascular diseases Narges AnsariSahar NajafiNajmaldin Saki ReviewPaper 22 May 2020 Pages: 89 - 95
Incidence and characteristics of spontaneous platelet macro-aggregation in acute ischemic stroke Tomohiro OsanaiKasumi MikamiMinoru Yasujima OriginalPaper 15 June 2020 Pages: 96 - 101
Network meta-analysis of anticoagulation strategies for venous thromboembolism in patients with cancer Hiroki UeyamaHirotaka MiyashitaToshiki Kuno OriginalPaper 26 May 2020 Pages: 102 - 111
Ph− myeloproliferative neoplasms and the related risk factors for stroke occurrence: Results from a registry of patients treated with Anagrelide Milan KošťálJiří Schwarzfor CZEMP–Czech Group for Ph- Myeloproliferative neoplasms OriginalPaper 23 June 2020 Pages: 112 - 119
Flow cytometric evaluation of platelet–leukocyte conjugate stability over time: methodological implications of sample handling and processing Ayesha SinghAmanda R. CoulterAndrew P. DeFilippis OriginalPaper 16 June 2020 Pages: 120 - 128
Long-term left atrial thrombi after mitral valve replacement Jindong ChenHao WangLiang Zhao OriginalPaper 19 June 2020 Pages: 129 - 135
Comparison of clinical performance of four gastrointestinal bleeding risk scores in Chinese patients with atrial fibrillation receiving oral anticoagulants Mei-na LvXiao-chun ZhengJin-hua Zhang OriginalPaper 27 May 2020 Pages: 136 - 142
Degree of luminal narrowing and composition of thrombus in plaque erosion Osamu KuriharaMasamichi TakanoIk-Kyung Jang OriginalPaper 29 May 2020 Pages: 143 - 150
Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products Renee CastilloAlissa ChanKendra Schomer OriginalPaper Open access 04 June 2020 Pages: 151 - 158
Acute revascularization treatments for ischemic stroke in the Stroke Units of Triveneto, northeast Italy: time to treatment and functional outcomes Manuel CappellariBruno BonettiPaolo Bovi OriginalPaper 18 May 2020 Pages: 159 - 167
Decreased size of the left anterior descending coronary artery is an independent predictor of deterioration in non-high-risk patients with acute pulmonary embolism Dong JiaYizhuo Gao OriginalPaper 20 May 2020 Pages: 168 - 175
Safety and efficacy of rt-PA treatment for acute stroke in pseudoxanthoma elasticum: the first report Silvia LanfranconiIsabella GhioneNereo Bresolin Report 26 May 2020 Pages: 176 - 179
Factors influencing early neurological improvement after mechanical thrombectomy among patients with acute basilar artery occlusion: a single center prospective observational cohort study Xuan SunHuijun ZhangZhongrong Miao OriginalPaper 02 June 2020 Pages: 180 - 186
Pregnancy and non-pregnancy related immune thrombotic thrombocytopenic purpura in women of reproductive age Amihai RottenstreichShira DorYosef Kalish OriginalPaper 09 May 2020 Pages: 187 - 193
Revascularization outcomes following acute ischemic stroke in patients taking direct oral anticoagulants: a single hospital cohort study Senta FrolMišo ŠabovičJanja Pretnar Oblak OriginalPaper 06 June 2020 Pages: 194 - 202
Impacts of in-hospital workflow on functional outcome in stroke patients treated with endovascular thrombectomy Dong YangWenjie Zithe ACTUAL Investigators OriginalPaper 10 June 2020 Pages: 203 - 211
Long-term outcome of patients with ST-segment elevation myocardial infarction treated with low-dose intracoronary thrombolysis during primary percutaneous coronary intervention: the 5-year results of the DISSOLUTION Trial Francesco PellicciaCesare GrecoCarlo Gaudio BriefCommunication 29 May 2020 Pages: 212 - 216
Value-based assessment of implementing a Pulmonary Embolism Response Team (PERT) Rahul AnnabathulaAdam DuganVedant A. Gupta OriginalPaper 15 June 2020 Pages: 217 - 225
Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory? Vera PaarBernhard WernlyMichael Lichtenauer BriefCommunication Open access 06 July 2020 Pages: 226 - 231
Highlights from the European society of cardiology congress 2020 Pooneh NabavizadehDylan L. Steen ReviewPaper 06 January 2021 Pages: 232 - 236
Aortic thrombus in patients with severe COVID-19: review of three cases María de CarranzaDanilo-Eduardo SalazarNuria Muñoz-Rivas Report 09 July 2020 Pages: 237 - 242
Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection Fergal McGlynnJennifer McGrathHelen Enright Letter to the Editor 24 August 2020 Pages: 243 - 245
Correction to: Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products Renee CastilloAlissa ChanKendra Schomer Correction 23 June 2020 Pages: 246 - 246
Correction to: Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products Renee CastilloAlissa ChanKendra Schomer Correction Open access 31 October 2020 Pages: 247 - 247